Skip to content

2021 Women's Venture Competition

The AIM-HI Accelerator Fund congratulates our women scientist-entrepreneur finalists and semi-finalists and their companies of the 2021 Women’s Venture Competition. The AIM-HI Women’s Venture Competition is a first-of-its-kind program that provides funding, coaching and networking opportunities to women-led oncology start-ups aimed to address unmet medical needs and compete for seed stage funding and prizes.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Finalists

Maria Varela photo

Maria Varela
CEO

Participating in the AIM-HI Women’s Venture Competition was an inflection point during ARDAN’s journey. The experience resulted in instructive and fruitful outcomes that have nourished our company and enlightened its future direction. This unique program offered our transformative woman-led biotech company a bridge to an elite network that is willing to help us, and others, in the pathway to creating life-saving technologies.”

Ronit SF

Ronit Satchi-Fainaro, Ph.D.
Co-Founder & CSO 

Semi-Finalists

Stacy Blain, Ph.D.
Founder & CSO

Concarlo Holdings
Amanda Schalk

Amanda Schalk, Ph.D.
COO

EBD_Logo Spec5
Johanna-Holldack

Johanna Holldack, M.D.
Founder & CEO

Kupando
Annelise Soulier

Annelise Soulier, Ph.D.
Co-Founder &  CSO

Cathy A. Swindlehurst

Cathy Swindlehurst, Ph.D.
CEO 

Amanda Guth

Amanda Guth, Ph.D.
Co-Founder & CSO 

Izabela-Tworowsska-PhD-LB-1

Izabela Tworowska, Ph.D.
Co-Founder & CSO 

RadioMedix
Martina Roos-2

 Martina Roos, Ph.D.
Co-Founder & CEO 

Sardona-Therapeutics

The AIM-HI Accelerator Fund congratulates our 10 women scientist-entrepreneur semi-finalists and their companies of the 2021 Women’s Venture Competition. The winning company of 2021 Women’s Venture Competition will receive a total of $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

In addition, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition …  but we can ALL Cast our Vote! 

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Back To Top